ADVERTISEMENT

Biocon Q1 Review - Covid Disruption Impacts Generics Sales, Earnings: Motilal Oswal

Biocon Q1 Review - Covid Disruption Impacts Generics Sales, Earnings: Motilal Oswal

An employee in protective clothing arranges samples inside the research and development center at the Biocon Ltd. campus in Bengaluru, India. (Photographer Dhiraj Singh/Bloomberg)
An employee in protective clothing arranges samples inside the research and development center at the Biocon Ltd. campus in Bengaluru, India. (Photographer Dhiraj Singh/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More